Seeking Alpha

cnylax44

cnylax44
Send Message
View as an RSS Feed
View cnylax44's Comments BY TICKER:
Latest  |  Highest rated
  • Sarepta Recovers Lost Ground With Bullish Analyst Activity [View article]
    FYI---Cowen does not see accelerated FDA review.
    Jan 28 06:28 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    Doing a great job on SPLK----wonder who gave you that one ????
    Jan 28 09:16 AM | Likes Like |Link to Comment
  • Today's Market News To Trade On: 5 Stocks Moving On News [View article]
    CRUS---buy high, sell low ??? that doesn't seem to be a very profitable strategy to me.
    Jan 15 03:09 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    Another good call ! If you throw out 10 per day you gotta be right on some. But when you get paid to promote by the article BUYER BEWARE !
    Jan 15 03:00 PM | Likes Like |Link to Comment
  • 'Top Of The Class' Small Pharma Investments For 2013 [View article]
    Check your market cap on ACRX---you're only off by 50-60% !! No $100 payment to you for your reporting --- too sloppy.
    Jan 14 12:37 PM | Likes Like |Link to Comment
  • Upcoming FDA Approval Decision Dates For Q1 2013 [View article]
    Nothing new here.
    Jan 14 11:14 AM | Likes Like |Link to Comment
  • This Cheap BioPharma Has Further Upside Ahead [View article]
    Wow !!! Two articles today....that's an easy $200 for reporting ! Hilarious ! Waiting to see what's next to come----can't wait !
    Jan 7 03:00 PM | Likes Like |Link to Comment
  • 2 Biotech Companies Making Considerable Strides When It Comes To Pain Management [View article]
    Surprised no summary from Yahoo on the companies----you always do this to collect the $100 for an "article". Outstanding----keep up the great work ! We can only wait for your next great summary !
    Jan 4 10:52 AM | Likes Like |Link to Comment
  • Positives Mounting For Priceline [View article]
    Give that man his $100 for "covering" PCLN ! Outstanding, leading edge !! Wow---reiterated Buy at TheStreet !!!
    Jan 4 10:46 AM | 1 Like Like |Link to Comment
  • One Biotech Making Significant Strides When It Comes To Lymph Node Discovery [View article]
    Pay that man his $100 for his article !!!
    Jan 4 10:28 AM | Likes Like |Link to Comment
  • AcelRx Pharma: Pain Drug Developer With A Pair Of Q1 2013 Phase III Catalysts [View article]
    Good summary.
    Dec 22 10:17 AM | 1 Like Like |Link to Comment
  • Alexion Pharmaceuticals: On The Road From Orphan Drugs To Blockbuster Profits [View article]
    How would you guess ? If you are part of these ultra-ophan sectors you either get the drug or die.
    Dec 10 08:47 AM | Likes Like |Link to Comment
  • Alexion Pharmaceuticals (ALXN -3.3%) dips after Citigroup intitiates coverage with a tepid Neutral rating, saying its current risk/reward profile isn't attractive. The firm notes that ALXN is presently trading at a very high P/E multiple that reflects optimistic expectations for upward EPS revisions. If history is a guide, the company will need to post significant upside surprises to offset the natural multiple contraction that is likely ahead. [View news story]
    WOW----leading edge research ! I wonder if this "analyst" will be one of the 11,000 employees on the chopping block ?
    Dec 7 12:47 PM | Likes Like |Link to Comment
  • Alexion Pharmaceuticals: On The Road From Orphan Drugs To Blockbuster Profits [View article]
    When you compare ALXN with other biotechnology companies it stands out as unique with no peers in the world. Factor in the outstanding management which has been led by a great CEO who founded the company over 20 years ago and you have a great recipe for successful investing.
    Dec 3 12:25 PM | Likes Like |Link to Comment
  • Betting Splunk Goes Splat [View article]
    No reason to think that the author remotely understands the technology or why it remotely stands a chance to be a technological game changer. When you're quickly off to comment on the retail industry before doubling back to update the world on the offshore energy industry, with a pit-stop in micro biotech -- then it becomes quite apparent that "rifle-shooting" from biotech to energy back to retail off to disrutive new technology renders the "author"....... ajack of all trades ? master of none ???
    Nov 29 10:26 PM | Likes Like |Link to Comment
COMMENTS STATS
92 Comments
27 Likes